Floatz logo

Dordaviprone

Colorectal Adenomatous Polyp

National Cancer Institute (NCI)Small moleculePhase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Colorectal Adenomatous Polyp cohort.

Asset / SponsorPhaseRating
Selenium
University of Arizona
Phase 3B
Docosahexaenoic Acid
Vanderbilt University
Phase 2B
Eicosapentanoic Acid
Vanderbilt University
Phase 2B
Acetylsalicylic Acid
University of Calgary
Phase 2CCC
TRIBENOSIDE
Lewai Sharki Abdulaziz, MSc PhD
Early Phase 1CC
CARTIA
Lewai Sharki Abdulaziz, MSc PhD
Early Phase 1CC
LIDOCAINE
Lewai Sharki Abdulaziz, MSc PhD
Early Phase 1CC
Glyceryl Trinitrate
Lewai Sharki Abdulaziz, MSc PhD
Early Phase 1CC

Same molecule, other indications

Dordaviprone is also rated in:

triple-negative breast carcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
glioblastomaDormant
CCC
Indicative ·
48 / 100
View asset →
triple-negative breast carcinomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →